Home » Newsletters » BioWorld

BioWorld

Dec. 9, 1993

View Archived Issues

SCICLONE FILES FOR FOLLOW-ON OFFERING

ATHENA UNDERWRITERS EXERCISE OPTION

LIFECELL TO TEAM UP WITH MEDTRONIC

ONCOGENE SCIENCE RECEIVES TWO PATENTS

ONCOSCINT PROSTATE EVALUATES PROSTATE CANCER

COCENSYS FILES INDS ON ANTI-EPILEPSY DRUG

IMMUNOGEN REPORTS ONCOLYSIN B PHASE II DATA

CELL THERAPEUTICS REPORTS ON IL-2 SIGNALING PATHWAY

NOVOPHARM AND DEPRENYL RESEARCH MARKETING ALLIANCE

PIG SEQUENCE DESIGNED TO FOIL FACTOR VIII INHIBITION

CISTRON SUES IMMUNEX OVER IL-1B PATENT

RHONE-POULENC GETS RIGHTS TO MARKET ENZON'S ONCASPAR

$5 BILLION NIH RESEARCH FUND PROPOSED

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...